| Alzheimer's Society

Rare gene variation associated with reduced risk of dementia

New research shows that a genetic variant of the PLCG2 gene may reduce the risk of developing some dementias and healthy ageing.

Potential for new dementia treatment following research trial

New research shows a link between reducing amyloid in the brain and slowing cognitive decline.

Research finds that there could be hope for new dementia treatment

New research shows that a study of the immunotherapy treatment Crenezumab has found it can reduce levels of the protein amyloid, associated with dementia.

Research finds it safe to open the blood-brain barrier in people affected by Alzheimer's disease

A phase 1 trial, reported in Nature Communications, has found that blood‒brain barrier (BBB) can be non-invasively and reversibly opened in five patients with Alzheimer’s disease.

Potential Alzheimer’s disease treatment fails trial

New research shows that a potential new drug to treat Alzheimer’s disease, Lanabecestat, has failed a phase 2/3 trial.

New research into air pollution and dementia finds link with cognitive ageing

New research shows that air pollution could have an effect on cognitive ageing.

See More